[Federal Register Volume 67, Number 17 (Friday, January 25, 2002)]
[Notices]
[Page 3711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1845]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-5:30 p.m., February 20, 2002, 8 a.m.-
3:45 p.m., February 21, 2002.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be discussed: The agenda will include a discussion on 
the adult harmonized schedule; yellow fever vaccine; update on 2001-
2002 influenza season; update on 2001-2002 influenza vaccine supply; 
update on pediatric influenza vaccination feasibility study; 
economics of vaccinating children for influenza; 2002 options for 
recommending influenza vaccine for children; 2002 Recommendations 
for Control and Prevention of Influenza; update on supplemental 
recommendations for use of anthrax vaccine; update on anthrax events 
and response; vaccinia (smallpox) vaccine safety; smallpox 
containment strategies; use of smallpox vaccine in the pre-attack 
setting; role of jet injectors in the event of a smallpox emergency; 
update on supply of smallpox vaccine and vaccinia immune globulin; 
updates from the National Immunization Program, Food and Drug 
Administration, Vaccine Injury Compensation Program, National 
Institutes of Health, National Vaccine Program, and National Center 
for Infectious Diseases; a discussion on rotavirus vaccine and 
intussusception; process of formulating the childhood harmonized 
immunization schedule; update on vaccine supply; and update on 
thimerosal.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 17, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-1845 Filed 1-24-02; 8:45 am]
BILLING CODE 4163-18-P